These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36358776)

  • 1. Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals.
    Poly TN; Islam MM; Walther BA; Lin MC; Li YJ
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal.
    Poly TN; Lin MC; Syed-Abdul S; Huang CW; Yang HC; Li YJ
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis.
    Zhou W; Chen X; Fan Q; Yu H; Jiang W
    Front Pharmacol; 2022; 13():979215. PubMed ID: 36188583
    [No Abstract]   [Full Text] [Related]  

  • 4. Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies.
    Hong HE; Kim AS; Kim MR; Ko HJ; Jung MK
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784492
    [No Abstract]   [Full Text] [Related]  

  • 5. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
    Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
    Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis.
    Laoveeravat P; Thavaraputta S; Vutthikraivit W; Suchartlikitwong S; Mingbunjerdsuk T; Motes A; Nugent K; Rakvit A; Islam E; Islam S
    QJM; 2020 Feb; 113(2):100-107. PubMed ID: 31503318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
    Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
    Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis.
    Guo H; Zhang R; Zhang P; Chen Z; Hua Y; Huang X; Li X
    Front Pharmacol; 2023; 14():1129948. PubMed ID: 37007006
    [No Abstract]   [Full Text] [Related]  

  • 9. Comprehensive analysis of proton pump inhibitors and risk of digestive tract cancers.
    Zeng R; Cheng Y; Luo D; Wang J; Yang J; Jiang L; Zhuo Z; Guo K; Wu H; Leung FW; Sha W; Chen H
    Eur J Cancer; 2021 Oct; 156():190-201. PubMed ID: 34481369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis.
    Alkhushaym N; Almutairi AR; Althagafi A; Fallatah SB; Oh M; Martin JR; Babiker HM; McBride A; Abraham I
    Expert Opin Drug Saf; 2020 Mar; 19(3):327-334. PubMed ID: 31928106
    [No Abstract]   [Full Text] [Related]  

  • 11. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
    Park CH; Kim EH; Roh YH; Kim HY; Lee SK
    PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
    Ma T; Wu M; Jia S; Yang L
    Int J Colorectal Dis; 2020 Dec; 35(12):2157-2169. PubMed ID: 32808072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis.
    Ahn N; Nolde M; Krause E; Güntner F; Günter A; Tauscher M; Gerlach R; Meisinger C; Linseisen J; Baumeister SE; Rückert-Eheberg IM
    Br J Clin Pharmacol; 2023 Feb; 89(2):602-616. PubMed ID: 36331350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis.
    Alhumaid S; Al Mutair A; Al Alawi Z; Zaidi ARZ; Rabaan AA; Elhazmi A; Al-Omari A
    Gut Pathog; 2021 Mar; 13(1):17. PubMed ID: 33741033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Zhao F; Wang J; Yang Y; Wang X; Shi R; Xu Z; Huang Z; Zhang G
    Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis.
    Peng TR; Wu TW; Li CH
    Int J Clin Oncol; 2023 Jan; 28(1):99-109. PubMed ID: 36224477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors on pancreatic cancer risk and survival.
    Kearns MD; Boursi B; Yang YX
    Cancer Epidemiol; 2017 Feb; 46():80-84. PubMed ID: 28056391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis.
    Song HJ; Jiang X; Henry L; Nguyen MH; Park H
    Eur J Clin Pharmacol; 2020 Jun; 76(6):851-866. PubMed ID: 32172363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies.
    Wu CC; Liao MH; Kung WM; Wang YC
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.